Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study
MS-Gait
1 other identifier
observational
300
1 country
1
Brief Summary
The primary objective of this project is to track changes over time in balance control parameters measured during stance and gait for different groups of multiple sclerosis (MS) patients. Our primary goal is to determine whether these changes in balance control over time predict transitions in MS progression to a more disease affected state, and are different from changes over time for patients with balance deficits due to vestibular sensory disorders. A part of this goal is also to determine whether these changes in balance control are correlated with changes in patients' self-reported deficits and are similar to those changes in balance control of patients with peripheral vestibular loss. The secondary objective is to determine for multiple sclerosis (MS) patients the relationship of their balance parameters to different gait speeds, in order to advise them on, and promote via feedback, safe walking speeds. Fulfilling the first of our objectives would lead to better tracking of MS disease changes over time, earlier quantification of onset of symptoms suggesting a worsening of disease status, and, we assume, greater patient satisfaction knowing that quantification of symptoms fits subjective feelings of balance deficits during stance and gait. Achieving the second objective would lead to improved balance during gait. We aim to carry out these objectives using equipment (SwayStar) which we have proven is sensitive to MS induced balance deficits {2}, but costs far less to operate and maintain than previously used quantification tools. We aim to investigate the balance deficits during gait in different MS patient groups using a multimodal approach with a SwayStar system (analysis of balance during stance and gait in terms of trunk-pelvis movements near the centre of mass) and patient questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2014
CompletedFirst Posted
Study publicly available on registry
May 20, 2014
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 6, 2025
April 1, 2025
7.7 years
May 16, 2014
April 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in balance during stance and gait
Measurement of trunk sway as balance measure during stance and gait trials
1 year
Study Arms (10)
RIS MS patients
Radiologically Isolated Syndrome (RIS) MS patients
CIS MS patients
Clinically Isolated Syndrome (CIS) patients during a stable phase
RRMS patients
Relapsing-remitting (RR) MS patients during a stable phase
SPMS Patients
Secondary progressive MS patients (SPMS)
PPMS Patients
Primary progressive MS patients (PPMS)
Controls
Age and gender matched controls
CI Patients
Cochlear Implant patients pre- and post-operatively
UVL Patients
Unilateral vestibular loss patients in acute and compensated state
Chronic UVL
Chronic unilateral vestibular loss patients
Phobic
Phobic vertigo patients
Eligibility Criteria
Patients with MS or UVL
You may qualify if:
- Balance deficits due to inner ear disease or MS
You may not qualify if:
- Inability to walk without a walking aid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lab for Exp Otoneurology, University Hospital Basel
Basel, CH-4031, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
John HJ Allum, DSc
University Hospital, Basel, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2014
First Posted
May 20, 2014
Study Start
April 1, 2018
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
April 6, 2025
Record last verified: 2025-04